128 related articles for article (PubMed ID: 37541472)
1. Gliadin nanoparticles for oral administration of bioactives: Ex vivo and in vivo investigations.
Voci S; Pangua C; Martínez-Ohárriz MC; Aranaz P; Collantes M; Irache JM; Cosco D
Int J Biol Macromol; 2023 Sep; 249():126111. PubMed ID: 37541472
[TBL] [Abstract][Full Text] [Related]
2. Development of polyoxyethylene (2) oleyl ether-gliadin nanoparticles: Characterization and in vitro cytotoxicity.
Voci S; Gagliardi A; Salvatici MC; Fresta M; Cosco D
Eur J Pharm Sci; 2021 Jul; 162():105849. PubMed ID: 33857638
[TBL] [Abstract][Full Text] [Related]
3. Development of antioxidant gliadin particle stabilized Pickering high internal phase emulsions (HIPEs) as oral delivery systems and the in vitro digestion fate.
Zhou FZ; Zeng T; Yin SW; Tang CH; Yuan DB; Yang XQ
Food Funct; 2018 Feb; 9(2):959-970. PubMed ID: 29322140
[TBL] [Abstract][Full Text] [Related]
4. Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics.
Arangoa MA; Campanero MA; Renedo MJ; Ponchel G; Irache JM
Pharm Res; 2001 Nov; 18(11):1521-7. PubMed ID: 11758758
[TBL] [Abstract][Full Text] [Related]
5. Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori.
Ramteke S; Jain NK
J Drug Target; 2008 Jan; 16(1):65-72. PubMed ID: 18172822
[TBL] [Abstract][Full Text] [Related]
6. Development of Pickering Emulsions Stabilized by Gliadin/Proanthocyanidins Hybrid Particles (GPHPs) and the Fate of Lipid Oxidation and Digestion.
Zhou FZ; Yan L; Yin SW; Tang CH; Yang XQ
J Agric Food Chem; 2018 Feb; 66(6):1461-1471. PubMed ID: 29350533
[TBL] [Abstract][Full Text] [Related]
7. Ascorbic acid-loaded gliadin nanoparticles as a novel nutraceutical formulation.
Voci S; Gagliardi A; Fresta M; Cosco D
Food Res Int; 2022 Nov; 161():111869. PubMed ID: 36192989
[TBL] [Abstract][Full Text] [Related]
8. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse.
Maisel K; Ensign L; Reddy M; Cone R; Hanes J
J Control Release; 2015 Jan; 197():48-57. PubMed ID: 25449804
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution and endocytosis of ICAM-1-targeting antibodies versus nanocarriers in the gastrointestinal tract in mice.
Mane V; Muro S
Int J Nanomedicine; 2012; 7():4223-37. PubMed ID: 22915850
[TBL] [Abstract][Full Text] [Related]
10. Gliadin Nanoparticles Pickering Emulgels for β-Carotene Delivery: Effect of Particle Concentration on the Stability and Bioaccessibility.
Cheng C; Gao Y; Wu Z; Miao J; Gao H; Ma L; Zou L; Peng S; Liu C; Liu W
Molecules; 2020 Sep; 25(18):. PubMed ID: 32932691
[TBL] [Abstract][Full Text] [Related]
11. The effect of thiamine-coating nanoparticles on their biodistribution and fate following oral administration.
Inchaurraga L; Martínez-López AL; Cattoz B; Griffiths PC; Wilcox M; Pearson JP; Quincoces G; Peñuelas I; Martin-Arbella N; Irache JM
Eur J Pharm Sci; 2019 Feb; 128():81-90. PubMed ID: 30472222
[TBL] [Abstract][Full Text] [Related]
12. Influence of the Dispersion Medium and Cryoprotectants on the Physico-Chemical Features of Gliadin- and Zein-Based Nanoparticles.
Voci S; Gagliardi A; Salvatici MC; Fresta M; Cosco D
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214063
[TBL] [Abstract][Full Text] [Related]
13. The nasal delivery of nanoencapsulated statins - an approach for brain delivery.
Clementino A; Batger M; Garrastazu G; Pozzoli M; Del Favero E; Rondelli V; Gutfilen B; Barboza T; Sukkar MB; Souza SA; Cantù L; Sonvico F
Int J Nanomedicine; 2016; 11():6575-6590. PubMed ID: 27994459
[TBL] [Abstract][Full Text] [Related]
14.
Martínez-López AL; González-Navarro CJ; Aranaz P; Vizmanos JL; Irache JM
Acta Pharm Sin B; 2021 Apr; 11(4):989-1002. PubMed ID: 33996411
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy and gastrointestinal biodistribution of polycationic nanoparticles for oral camptothecin delivery in early and late-stage colorectal tumor-bearing animal model.
Ünal S; Can Öztürk S; Bilgiç E; Yanık H; Korkusuz P; Aktaş Y; Benito JM; Esendağlı G; Bilensoy E
Eur J Pharm Biopharm; 2021 Dec; 169():168-177. PubMed ID: 34700001
[TBL] [Abstract][Full Text] [Related]
16. Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats.
Bimbo LM; Sarparanta M; Santos HA; Airaksinen AJ; Mäkilä E; Laaksonen T; Peltonen L; Lehto VP; Hirvonen J; Salonen J
ACS Nano; 2010 Jun; 4(6):3023-32. PubMed ID: 20509673
[TBL] [Abstract][Full Text] [Related]
17. Gliadin Nanoparticles Containing Doxorubicin Hydrochloride: Characterization and Cytotoxicity.
Voci S; Gagliardi A; Ambrosio N; Salvatici MC; Fresta M; Cosco D
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678809
[TBL] [Abstract][Full Text] [Related]
18. Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract.
Ball RL; Bajaj P; Whitehead KA
Sci Rep; 2018 Feb; 8(1):2178. PubMed ID: 29391566
[TBL] [Abstract][Full Text] [Related]
19. Effect of sodium tripolyphosphate incorporation on physical, structural, morphological and stability characteristics of zein and gliadin nanoparticles.
Yang S; Dai L; Mao L; Liu J; Yuan F; Li Z; Gao Y
Int J Biol Macromol; 2019 Sep; 136():653-660. PubMed ID: 31195045
[TBL] [Abstract][Full Text] [Related]
20. Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure.
Lee CM; Jeong HJ; Yun KN; Kim DW; Sohn MH; Lee JK; Jeong J; Lim ST
Int J Nanomedicine; 2012; 7():3203-9. PubMed ID: 22811605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
